Solesence (NASDAQ:SLSN – Get Free Report) and BioHarvest Sciences (NASDAQ:BHST – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, profitability, institutional ownership and earnings.
Valuation & Earnings
This table compares Solesence and BioHarvest Sciences”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Solesence | $62.06 million | 0.98 | $1.79 million | ($0.03) | -28.57 |
| BioHarvest Sciences | $34.51 million | 0.90 | -$11.14 million | ($0.52) | -3.06 |
Risk and Volatility
Solesence has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500.
Profitability
This table compares Solesence and BioHarvest Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Solesence | -3.40% | -11.58% | -3.79% |
| BioHarvest Sciences | -31.21% | -58.30% | -25.60% |
Analyst Ratings
This is a summary of recent recommendations and price targets for Solesence and BioHarvest Sciences, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Solesence | 1 | 0 | 0 | 0 | 1.00 |
| BioHarvest Sciences | 1 | 0 | 2 | 0 | 2.33 |
BioHarvest Sciences has a consensus price target of $6.50, indicating a potential upside of 308.81%. Given BioHarvest Sciences’ stronger consensus rating and higher possible upside, analysts clearly believe BioHarvest Sciences is more favorable than Solesence.
Insider & Institutional Ownership
70.2% of Solesence shares are held by institutional investors. 4.8% of Solesence shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Solesence beats BioHarvest Sciences on 10 of the 14 factors compared between the two stocks.
About Solesence
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.
About BioHarvest Sciences
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.
